We have attempted to characterize the molecular defect in a temperature-sensitive mutant of vaccinia virus, ts22, which has an abortive late phenotype. At Vaccinia virus, a prototypical member of the poxvirus family, contains a linear double-stranded DNA genome of approximately 180,000 base pairs. It therefore contains sufficient information to encode 100 to 200 polypeptides. Unlike other eucaryotic DNA viruses, which have an obligatory nuclear phase, the poxviruses replicate exclusively in the cytoplasm of susceptible host cells. Vaccinia virus therefore encodes an array of enzymes essential for DNA and RNA metabolism (reviewed in references 12 and 22). Vaccinia virus provides a unique system not only for studying the regulation of eucaryotic gene expression independently of the host but also for studying virus-host interactions.
cleavage of rRNA, suggesting that the ts22 and drug inhibitor may function in the same pathway.
Vaccinia virus, a prototypical member of the poxvirus family, contains a linear double-stranded DNA genome of approximately 180,000 base pairs. It therefore contains sufficient information to encode 100 to 200 polypeptides. Unlike other eucaryotic DNA viruses, which have an obligatory nuclear phase, the poxviruses replicate exclusively in the cytoplasm of susceptible host cells. Vaccinia virus therefore encodes an array of enzymes essential for DNA and RNA metabolism (reviewed in references 12 and 22) . Vaccinia virus provides a unique system not only for studying the regulation of eucaryotic gene expression independently of the host but also for studying virus-host interactions.
Several laboratories have recognized the need for a thorough genetic analysis of the vaccinia virus. This has resulted in the isolation and characterization of a large number of temperature-sensitive mutants of vaccinia virus (4-6, 11, 15, 16) . The isolation and preliminary characterization of 65 temperature-sensitive mutants of vaccinia virus representing 32 complementation groups have been described (5, 6) . These studies revealed four biochemical phenotypes based on the ability of the mutants to synthesize viral DNA and viral proteins at the permissive and nonpermissive temperatures: (i) a normal phenotype (mutants are indistinguishable from the wild type [WT]), (ii) a DNA-negative phenotype (mutants do not synthesize viral DNA or late proteins at the nonpermissive temperature), (iii) a defective late phenotype (normal DNA synthesis and weak or delayed late viral protein synthesis at the nonpermissive temperature), and (iv) an abortive late phenotype (normal DNA synthesis, but late viral protein synthesis which starts normally at the nonpermissive temperature and then ceases abruptly).
The abortive late phenotype is particularly interesting because it suggests either a defect in the synthesis, function, * Corresponding author.
or stability of late viral mRNA or a perturbation in some other host-virus interaction necessary for continued late viral protein synthesis. These hypotheses prompted us to characterize further the defect in one abortive late mutant, ts22.
In this report, we show that late during a ts22 infection at the nonpermissive temperature, at the time when viral protein synthesis aborts, rRNA and viral mRNA are degraded. This indicates that vaccinia virus encodes a function which prevents a virus-induced breakdown of host rRNA and viral mRNA.
The abortive late protein synthesis pattern observed during infection by ts22 under nonpermissive conditions (5) is virtually identical to the pattern observed when a vaccinia virus infection is carried out in the presence of the antipoxvirus drug isatin-p-thiosemicarbazone (IBT) (24, 28, 34) . We report here that rRNA is degraded at the time that viral protein synthesis aborts in a vaccinia virus infection in the presence of IBT. This suggests that the ts22 and IBT inhibitors may function in the same pathway.
The pattern of rRNA degradation in a ts22 infection at the nonpermissive temperature is strikingly similar to that observed in interferon-treated, vaccinia virus-infected mouse L cells (17, 18) . Therefore, we must consider the possibility that the phenomenon we are observing is related to the defense of the virus against an antiviral state. This possibility will be discussed.
MATERIALS AND METHODS
Cells and virus. BSC40 cells, WT vaccinia virus strain WR, ts22, and all conditions for virus growth, infection, and plaque titration have been described in detail previously (5, 6) . IBT (Pfaltz and Bauer, Inc.) was dissolved in acetone at a concentration of 5 mg/ml and then diluted with 4 RNA synthesis. Dishes (35 mm) of BSC40 cells were infected with 0.25 ml of the WT or ts22 in phosphatebuffered saline (PBS), pH 7, at a multiplicity of infection of 20. After a 30-min absorption period at 31 or 40°C, 2 ml of warm medium was added to the infected dishes, and incubation was continued. At various times after infection, the medium was removed and the infected cells were pulselabeled with 0.5 ml of [3H]uridine (20 , uCi/ml in PBS, specific activity 14 Ci/mmol; ICN Chemicals and Radioisotopes Division) for 12 min. The label was then removed, and 1 ml of lysis buffer containing 10 mM Tris hydrochloride, pH 8.0, 1 mM MgC92, and 1% Triton X-100 was added. The cells were scraped from the dishes and transferred to chilled tubes. The samples were incubated on ice for 10 min and vortexed occasionally. The cells were then spun at 1,000 x g for 10 min at 4°C to remove the nuclei. Cold 10% trichloroacetic acid (TCA) (1 ml) was added to 1 ml of the supernatant. A 1-ml amount of this solution was filtered on a Whatman GF/C filter, washed twice with cold 5% TCA and once with ethanol, air dried, and counted in a liquid scintillation counter.
Isolation of total RNA from infected cells. Dishes (100 mm) of BSC40 cells were infected with 1.5 ml of WT Whatman 3MM filters and processed to determine the hot TCA-precipitable radioactivity as described previously (7) .
Electrophoretic analysis of RNA. Glyoxylated samples of RNA were electrophoresed on a 1.8% agarose gel in 5 mM sodium phosphate buffer (pH 7.0) and stained with ethidium bromide (29) . Glyoxal (Matheson, Coleman and Bell, Norwood, Ohio) was deionized and stored as described previously (32) . For Northern analysis, RNA gels were transferred to hybridization transfer membranes (Gene Screen, New England Nuclear Corp.) essentially as described by Southern (30) . Before transfer, the membrane was soaked in 12.5 mM sodium phosphate buffer (pH 6.5) for 15 to 20 min. The transfer buffer used was 12.5 mM sodium phosphate buffer (pH 6.5). After transfer, the membrane was rinsed in 12.5 mM sodium phosphate buffer (pH 6.5) to remove residual agarose. The membrane was dried, baked at 80°C for 3 h, and prehybridized at 42°C for 12 h. The prehybridization buffer contained 50% formamide (deionized), 0.2% polyvinylpyrrolidone (molecular weight [MW] 40,000), 0.2% bovine serum albumin, 0.2% Ficoll (MW 400,000), 0.05 M Tris hydrochloride (pH 7.5), 1.0 M NaCl, 0.1% sodium pyrophosphate, 1.0% SDS, 10% dextran sulfate (MW 500,000), and denatured salmon sperm DNA (>100 ,ug/ml). A cloned 2.0-kilobase (kb) ClaI-BglII subfragment of the HindIII-E region of the vaccinia virus genome (obtained from P. Traktman), which contains half of the vaccinia virus DNA polymerase gene (33) , was labeled by nick translation as described above and used as a hybridization probe. The probe was denatured by boiling at 100°C for 15 min, followed by quick cooling. Hybridization was carried out at 42°C for 18 h with the prehybridization buffer containing the denatured radioactive probe. After hybridization, the membrane was washed twice for 20 min in 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at room temperature, then once in 2x SSC containing 1.0% SDS at 65°C for 1 to 2 h, and finally in 0.1x SSC at room temperature for 1 to 2 h. The membrane was dried and autoradiographed as described above. We assayed viral RNA synthesis by pulse-labeling with tritiated uridine and by RNA dot-blot hybridization. Since vaccinia virus replicates in the cytoplasm of host cells, virus-specific RNA can be identified by its site of synthesis. When infected cells are pulse-labeled with tritiated uridine for less than 12 min, virtually all of the labeled material in the cytoplasm is viral RNA (2) . Therefore, viral RNA synthesis in WT-and ts22-infected cells at 31 and 40°C was compared by measuring incorporation of tritiated uridine into TCAprecipitable material in the cytoplasm of infected cells (Fig.  2) . Since the vaccinia virus infectious cycle proceeds faster at 40 than at 31°C, the rate of incorporation of [3H]uridine into vaccinia virus mRNA was greater at 40 than at 31°C. The pattern of uridine labeling during ts22 and wt infection at 40°C was virtually identical (Fig. 2) .
RESULTS
The steady-state concentration of viral RNA sequences in ts22-and WT-infected cells at 31 and 40°C was quantitated by RNA dot-blot hybridization (Fig. 3A) . Individual dots were excised, and radioactivity was determined (Fig. 3B) (8) .
The products of the in vitro translation reactions were analyzed by SDS-polyacrylamide gel electrophoresis (data not shown) and by incorporation of [35S]methionine into TCA-precipitable material (Fig. 4) . Total RNA obtained at 8 h postinfection from Wr-and ts22-infected cells at 31 and 40°C stimulated amino acid incorporation to a similar extent (Fig. 4A) . In contrast, total RNA isolated from ts22-infected cells at 40°C at 14 h postinfection did not stimulate the incorporation of [35S]methionine into proteins (Fig. 4B) . In vitro translation reactions were also done with total RNA extracted at 2, 4, 6, 10, 12, and 16 labeling seen in vivo by 2 to 4 h. Possible explanations for this lag will be discussed (see Discussion).
Structural analysis of RNA from infected cells. A plausible explanation for all of the above observations is that late during a ts22 infection at 40°C viral mRNA is cleaved to a functionally inactive form. We therefore decided to measure the size of viral RNA by Northern analysis (32) . Total RNA extracted from WT-and ts22-infected cells at 31 and 40°C at 2, 4, 6, 8, and 14 h postinfection was denatured and electrophoresed on agarose gels. Before Northern analysis, the RNA was visualized by staining with ethidium bromide (Fig.  5) . We discovered that rRNA was degraded into discrete products at 8 and 14 h postinfection in ts22-infected cells at 40°C (Fig. 5) . This was not observed in a WT infection at 31 or 40°C, in a ts22 infection at 31°C, or early during a ts22 infection at 40°C (Fig. 5) . Specifically, degradation of 28S rRNA was virtually complete. It is not clear whether the band comigrating with 18S rRNA represents intact 18S rRNA or partially degraded 28S rRNA. The time during infection that degradation of rRNA was observed coincided with the abrupt shutoff of viral protein synthesis.
To measure the size of the late viral transcripts by Northern analysis, it would be necessary to use a specific vaccinia virus late gene as a probe. However, late vaccinia virus transcripts are extremely heterogeneous in length at their 3' ends, presumably due to inefficient termination of transcription (10, 21) . Thus, a discrete late gene may encode a family of transcripts, many of which are much larger than necessary to synthesize the polypeptide encoded by the gene. Precise information about the structural integrity of the late viral mRNA could be complicated by this size heterogeneity in the normal transcripts. We found, however, that almost any DNA probe in the Northern analysis yielded evidence of mRNA cleavage. An example is shown (Fig. 6 ) for a DNA fragment from the vaccinia virus DNA polymerase gene. This gene is transcribed early during infection into two mRNAs, 3.9 and 3.4 kb long (33) . Early during WT or ts22 infection at 31 or 40°C (2 h postinfection), the probe hybridized to the 3.9-and 3.4-kb transcripts (33; data not shown). At 6 and 8 h postinfection, in addition to the DNA polymerase transcripts, RNA in the size range of >5 kb was also detected. This may represent transcription from a late promoter through the DNA polymerase gene. In ts22-infected cells at 40°C at 8 h postinfection, the 3.4-kb DNA polymerase transcript disappeared and a 2.6-kb transcript, a 1.8-kb transcript, and RNAs of 800 base pairs and smaller were detected instead. The simplest interpretation of these observations that is consistent with the data presented in Fig. 4 non, which ultimately results in rRNA breakdown, can be blocked by a protection function synthesized by the virus. In this fashion, the balance between the two opposing processes is maintained for a productive viral infection. In the abortive late mutant this balance is completely tilted in favor of the induction process, which continues unabated. Therefore, ts22 provides a system for assaying the induction process in the absence of interference from the protection phenomenon. Deductions can be made about the protection phenomenon by comparing ts22 infection with WT infection, in which both induction and protection processes occur.
To determine whether induction requires early or late viral gene expression, we assayed for rRNA breakdown late during a ts22 infection carried out at 40°C in the presence of cytosine arabinoside (ara-C), which prevents late vaccinia virus gene expression. If induction requires early viral protein synthesis, rRNA cleavage should occur in the presence of ara-C; but if induction requires only late viral protein synthesis, then rRNA breakdown should be prevented by ara-C. Cells were infected with ts22 and incubated at 40°C for 10 h in the presence or absence of ara-C. Total RNA extracted from these cells was denatured, electrophoresed on an agarose gel, and stained with ethidium bromide (Fig. 7 , lane e). rRNA was intact in ts22-infected cells treated with ara-C, demonstrating that induction requires late viral gene expression.
We attempted to determine whether protection requires early or late viral gene expression by examining the effect of adding cycloheximide (Cx) at different times on rRNA integrity in WT-and ts22-infected cells. In this experiment, Cx was added at 0, 2, 4, 6, and 8 h after a WT infection or at 0, 4, and 6 h after a ts22 infection. Infected cells were incubated at 40°C for a total period of 10 h. At the end of the incubation period, total RNA was extracted, denatured, electrophoresed on an agarose gel, and stained with ethidium bromide (Fig. 7) . When viral protein synthesis was inhibited at 0 or 4 h after infection with ts22, rRNA breakdown was not observed. When Cx was not added until 6 h postinfection, rRNA breakdown occurred. This suggests that induction requires protein synthesis between 4 and 6 h postinfection. This result is consistent with the conclusion drawn from the experiment with ara-C, that induction is a late viral phenomenon. rRNA breakdown was less pronounced when
Cx was added at 6 h after infection (Fig. 7, lane c) than in an untreated control (Fig. 7, lane d) . This suggests that complete induction requires continued protein synthesis between 6 and 10 h postinfection. During a WT infection, rRNA breakdown was observed when Cx was added at 4 or 6 h after infection but not when it was added at 0, 2, or 8 h after infection. The rRNA breakdown was much less pronounced than in a ts22 infection. The results obtained for a WT infection represent the combined effects of the induction and protection processes. Although significant protection was apparent by 6 h postinfection, it was still not sufficient to corppletely block the induction process. However, by 8 h in a WT infection, the induction process had been completely inhibited. rRNA breakdown was observed earlier in the WT infection than in the ts22 infection, probably because of BSC40 cells were infected with ts22 (lanes a through e) or WT (lanes f through k) at 15 PFU/ml. Cx (300 ,ug/ml) was added to the monolayers 20 min before infection (lanes a and f) or 90 min (lane g), 4 h (lanes b and h), 6 h (lanes c and i) or 8 h (lane j) after infection. Ara-C (40 ,ug/ml) was added to ts22-infected cells 20 In conclusion, the results with the WT and ts22 together show that induction and protection occur simultaneously and require protein synthesis from 4 through 8 h after infection.
Effect of IBT on RNA stability in infected cells. IBT, a potent inhibitor of poxvirus replication (28) , severely restricts the synthesis of late viral proteins (24, 34 Fig. 2 and 3 ), (ii) late viral mRNA is biologically inactive since it cannot stimulate in vitro protein synthesis (Fig. 4) , and (iii) a late viral component serves as an inducer for rRNA breakdown (Fig. 7) . rRNA was similarly degraded in vaccinia virus-infected, IBT-treated cells (Fig. 8) , which suggests that the ts22 and IBT inhibitors may function in the same pathway.
Cleavage of both rRNA and mRNA resulted in a characteristic electrophoretic pattern of breakdown products. The reasons for this specific cleavage pattern are unclear. One possibility is that the enzyme responsible for RNA cleavage is sequence specific. Alternatively, the pattern may be dictated by the complex secondary structure of the 28S and 18S rRNA molecules or by protection by ribosomal proteins. The specific cleavage products observed in vaccinia virus mRNAs could be explained in a similar fashion.
We must consider the possibility that the rRNA and mRNA degradation observed in ts22-infected cells is not the primary effect of a mutation in the ts22 gene but rather a generalized, indirect protein synthesis was inhibited did not result in the breakdown of RNA: (i) when vaccinia virus-infected cells were treated with Cx ( Fig. 7) and (ii) during infection with NG26, a temperature-sensitive, phosphonoacetic acid-resistant vaccinia virus mutant in which viral protein synthesis ceased at 40°C at 8 h postinfection (data not shown). These results indicate that breakdown is directly related to a specific lesion in ts22. We therefore favor the interpretation that breakdown is actually a cause of the abortive infection rather than an artifact of a nonspecific inhibition of protein synthesis.
We have noted that the decay of mRNA template activity as assayed in vitro lags behind the decay measured in vivo by 2 to 4 h (compare Fig. 1B, 8 h, with Fig. 4A ). There are two possible explanations for this lag. First, it is possible that the in vitro protein synthesis system is not as sensitive to mRNA degradation as the in vivo system is. A more interesting explanation is that the decay of protein synthesis observed in vivo represents the combined effects of rRNA and mRNA breakdown. Thus, when partially degraded mRNA from infected cells is added to an in vitro system containing intact ribosomes, more protein synthesis is observed than was observed in vivo.
The simplest explanation of the rRNA degradation phenomenon is that viral infection triggers two processes, induction and protection. We define the induction phenomenon as a process whose activation ultimately results in the cleavage of rRNA and late viral mRNA. The induction pathway was inhibited by ara-C (Fig. 7, lane e) 20) . This 2-5A pathway is only one of at least two mechanisms proposed for the antiviral effects of interferon. In the second pathway, viral dsRNA activates a proteir, kinase which phosphorylates the small subunit of a eucaryotic initiation factor, eIF-2, thereby inactivating it and leading to inhibition of protein synthesis (reviewed in reference 1). The only feature common to both pathways (besides blocking viral growth) is that the inducer is viral dsRNA.
Given the similarity in rRNA degradation patterns in ts22-infected cells and interferon-treated, vaccinia virusinfected cells, it is tempting to hypothesize that the phenotype of a ts22 infection represents the uncontrolled induction of the RNase L pathway. A logical extension of this hypothesis is that the protector function that we believe is defective in ts22 normally serves to counteract the antiviral state. There is biological evidence to support this speculation. First, vaccinia virus can rescue vesicular stomatitis virus from the inhibitory effects of interferon in doubly infected interferon-treated cells (13, 31) . Second, vaccinia virus is refractory to inhibition by interferon in certain cell lines, such as HeLa, CV1, and L929, despite an active 2-5A-dependent RNase (25) . Attempts to precisely characterize the vaccinia virus-mediated inhibition of the antiviral state have revealed the existence of a virus-encoded inhibitor of the dsRNA-dependent protein kinase (14, 26) . It has also been proposed that vaccinia virus may encode an inhibitor of RNase L (25) .
Despite the similarity of the rRNA degradation pattern, several observations are inconsistent with the hypothesis that the phenomenon seen in ts22-infected cells is directly correlated to the interferon-induced RNase L. First, in all of the studies cited above, pretreating the infected cells with interferon is obligatory, whereas in a ts22 infection interferon is not added. Second, in several attempts (e.g., rescue of vesicular stomatitis virus and the protein kinase inhibitory factor) to determine whether the defense function encoded by vaccinia virus against the antiviral state is induced early or late, it has been shown to be an early viral function (13, 31) . In contrast, preliminary evidence from our studies with Cx ( Fig. 7) indicate that protection is a late viral phenomenon. Third, rRNA degradation in interferon-treated, vaccinia virus-infected cells occurs as early as 30 min postinfection, and by 2 h after infection much of the 28S and 18S species have been degraded (17, 18) . It is therefore apparent that the induction of interferon-induced RNase L is an early viral event. In contrast, ara-C experiments in ts22-infected cells (Fig. 7) showed that induction of rRNA breakdown is a late viral phenomenon. In light of these inconsistencies, it is important to reemphasize that the only similarity is in the pattern of rRNA degradation. It seems possible that the phenomenon we observed in the abortive late mutant may involve interferon-induced RNase L, but in ways we do not fully comprehend.
